MedPath

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Recruiting
Conditions
Diabetic Retinopathy
Registration Number
NCT06478407
Lead Sponsor
Li Xiaorong
Brief Summary

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ,improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Detailed Description

West of the city, and hebei, heping and binhai new area to carry out the work, diabetic retinopathy screening on 18000 diabetic patients in fundus examination. Tianjin medical university eye hospital, project team, formed in grassroots medical institutions are responsible for screening fundus examination in patients with diabetes, related inspection including vision, computer optometry, fundus photography and optical coherence tomography angiography (OCTA), etc. Blood samples were collected from patients in Hexi District and Heping District to detect glycosylated hemoglobin. Glycated albumin, urine ACR and CO breath test were performed in Chu Hsien-I Memorial Hospital of Tianjin Medical University. Health records were established for the screening personnel after the examination

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
18000
Inclusion Criteria
  • 1: Clear awareness, barrier-free communication

2: diabetes

Exclusion Criteria
  • 1: Have left the registered home address

    2: In the last 6 months, you have not lived in your place of residence

    3: Have a serious mental illness

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Classification of diabetic retinopathyAt screening

Fundus images were taken by fundus camera and graded

Secondary Outcome Measures
NameTimeMethod
blood routine examinationAt screening

Blood was collected and tested

glycated albuminAt screening

Blood was collected and tested

blood biochemistryAt screening

Blood was collected and tested

Blood vessel color Doppler ultrasound of extremitiesAt screening

Blood vessels of extremities were photographed by color Doppler ultrasound

OCTA imaging indicatorsAt screening

OCTA machine was used to photograph the fundus

Urine ACRAt screening

Urine was collected and tested

glycosylated hemoglobinAt screening

Blood was collected and tested

Trial Locations

Locations (1)

Tianjin Medical University Eye Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin Medical University Eye Hospital
🇨🇳Tianjin, Tianjin, China
Juping Liu
Contact
13752033227
tydljp@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.